| 2922.21 | | Amino-naphthols and other amino-phenols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof: | | | | |
| 2922.31.00 | 00 | Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof: | | | | |
| 2922.41.00 | | Amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof: | | | | |
| 2923.20.10 | 00 | Purified egg phospholipids, pharmaceutical grade meeting requirements of the U.S. Food and Drug Administration, for use in intravenous fat emulsion | kg | Free | | 16.5￠/kg + 30% |
| 2924.29.03 | 00 | 3,5-Dinitro-o-toluamide | kg | Free | | 15.4￠/kg + 47.5% |
| 2925.19.70 | 00 | N-Chlorosuccinimide; and N,N'-Ethylenebis(5,6-dibromo-2,3- norbornanedicarboximide) | kg | Free | | 25% |
| 2930.90.43 | 20 | Compounds containing a phosphorus atom to which is bonded one methyl, ethyl, n-propyl or isopropyl group, but no other carbon atoms | kg | | | |
| 2930.90.91 | 25 | Other compounds containing a phosphorus atom to which is bonded one methyl, ethyl, n-propyl or isopropyl group, but no other carbon atoms Other: | kg | | | |
| 2931.00.90 | 41 | Containing a phosphorus atom to which which is bonded one methyl, ethyl, n-propyl or isopropyl group, but no other carbon atoms | kg | | | |
| 2932.11.00 | 00 | Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.11.00 | 00 | Compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.21.00 | 00 | Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.31.00 | 00 | Compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure: | | | | |
| 2933.39.08 | 00 | 1-(3-Sulfopropyl)pyridinium hydroxide; N,N'-Bis(2,2,6,6-tetramethyl-4-piperidinyl)-1,6- hexanediamine; 3,5-Dimethyl-2-hydroxymethyl-4-methoxy- pyridine (pyrmethyl alcohol); Dipentamethylenethiuram tetrasulfide; 2H-Indol-2-one,1,3-dihydro-1-phenyl-3-(4- pyridinylmethylene); 4-Picolyl chloride hydrochloride; and Piperidinoethyl chloride hydrochloride | kg | Free | | 15.4￠/kg + 52% |
| 2933.39.20 | 00 | p-Chloro-2-benzylpyridine; 4-Chloro-1-methylpiperidine hydrochloride; 1,4-Dimethyl-6-hydroxy-3-cyanopyrid-2-one; Di-(2,2,6,6-tetramethyl-4-hydroxy- piperidine)sebacate; 2-Methyl-5-ethylpyridine; 4-Phenylpropylpyridine; α-Phenylpyridylacetic acid, methyl ester; Picolinic acid; 2-Pyridinecarboxaldehyde; and 2,5-Pyridinedicarboxylic acid | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4￠/kg + 39.5% |
| 2933.41.00 | 00 | Compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2933.52 | | Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure: | | | | |
| 2933.61.00 | 00 | Compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure: | | | | |
| 2934.10 | | Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure: | | | | |
| 2934.20 | | Compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2934.30 | | Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused: | | | | |
| 2939.20.00 | 10 | Quinine and its salts | g | | | |
| 3003.10.00 | 00 | Containing penicillins or derivatives thereof, with a penicillanic acid structure, or streptomycins or their derivatives | kg | Free | | 15.4￠/kg + 49% |
| 3003.20.00 | 00 | Containing other antibiotics Containing hormones or other products of heading 2937 but not containing antibiotics: | kg | Free | | 25% |
| 3003.31.00 | 00 | Containing insulin | kg | Free | | 25% |
